CDC Grand Rounds: Improving Medication Adherence for Chronic Disease Management - Innovations and Opportunities
Insights
Medication nonadherence leads to poor health outcomes and billions in U.S. healthcare costs annually. Improving adherence is crucial for public health and reducing disease burdens.
Area of Science:
- Pharmacology and Public Health
- Health Economics
Background:
- Medication adherence significantly impacts chronic disease management and mortality rates.
- Nonadherence is linked to increased hospital admissions, poorer health, and higher healthcare expenditures.
- Despite stable nonadherence rates, associated costs have escalated to $100-$300 billion annually in the U.S.
Purpose of the Study:
- To highlight the critical importance of medication adherence in managing chronic conditions.
- To underscore the substantial economic and health consequences of medication nonadherence.
- To emphasize the public health priority of improving medication adherence.
Main Methods:
- Literature review and synthesis of existing data on medication adherence and nonadherence.
- Analysis of prescription data and associated healthcare costs in the United States.
- Examination of clinical outcomes linked to adherence versus nonadherence.
Main Results:
- Approximately 20% of new prescriptions are never filled.
- About 50% of filled prescriptions are taken incorrectly regarding dose, timing, frequency, or duration.
- Annual direct healthcare costs attributed to nonadherence range from $100 billion to $300 billion in the U.S.
Conclusions:
- Improving medication adherence is essential for enhancing patient outcomes and reducing mortality.
- Addressing medication nonadherence can significantly alleviate the economic and health burdens of chronic diseases.
- Enhancing adherence represents a key public health strategy for a healthier population and a more sustainable healthcare system.
Abstract:
Adherence to prescribed medications is associated with improved clinical outcomes for chronic disease management and reduced mortality from chronic conditions (1). Conversely, nonadherence is associated with higher rates of hospital admissions, suboptimal health outcomes, increased morbidity and mortality, and increased health care costs (2). In the United States, 3.8 billion prescriptions are written annually (3). Approximately one in five new prescriptions are never filled, and among those filled, approximately 50% are taken incorrectly, particularly with regard to timing, dosage, frequency, and duration (4). Whereas rates of nonadherence across the United States have remained relatively stable, direct health care costs associated with nonadherence have grown to approximately $100-$300 billion of U.S. health care dollars spent annually (5,6). Improving medication adherence is a public health priority and could reduce the economic and health burdens of many diseases and chronic conditions (7).
